These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 11553625)
1. Identification of determinants of inverse agonism in a constitutively active parathyroid hormone/parathyroid hormone-related peptide receptor by photoaffinity cross-linking and mutational analysis. Gensure RC; Carter PH; Petroni BD; Jüppner H; Gardella TJ J Biol Chem; 2001 Nov; 276(46):42692-9. PubMed ID: 11553625 [TBL] [Abstract][Full Text] [Related]
2. Multiple sites of contact between the carboxyl-terminal binding domain of PTHrP-(1--36) analogs and the amino-terminal extracellular domain of the PTH/PTHrP receptor identified by photoaffinity cross-linking. Gensure RC; Gardella TJ; Jüppner H J Biol Chem; 2001 Aug; 276(31):28650-8. PubMed ID: 11356832 [TBL] [Abstract][Full Text] [Related]
3. Photoaffinity cross-linking identifies differences in the interactions of an agonist and an antagonist with the parathyroid hormone/parathyroid hormone-related protein receptor. Behar V; Bisello A; Bitan G; Rosenblatt M; Chorev M J Biol Chem; 2000 Jan; 275(1):9-17. PubMed ID: 10617579 [TBL] [Abstract][Full Text] [Related]
4. Selective and nonselective inverse agonists for constitutively active type-1 parathyroid hormone receptors: evidence for altered receptor conformations. Carter PH; Petroni BD; Gensure RC; Schipani E; Potts JT; Gardella TJ Endocrinology; 2001 Apr; 142(4):1534-45. PubMed ID: 11250934 [TBL] [Abstract][Full Text] [Related]
5. Identification of a contact site for residue 19 of parathyroid hormone (PTH) and PTH-related protein analogs in transmembrane domain two of the type 1 PTH receptor. Gensure RC; Shimizu N; Tsang J; Gardella TJ Mol Endocrinol; 2003 Dec; 17(12):2647-58. PubMed ID: 12947048 [TBL] [Abstract][Full Text] [Related]
6. Evidence for a ligand interaction site at the amino-terminus of the parathyroid hormone (PTH)/PTH-related protein receptor from cross-linking and mutational studies. Mannstadt M; Luck MD; Gardella TJ; Jüppner H J Biol Chem; 1998 Jul; 273(27):16890-6. PubMed ID: 9642250 [TBL] [Abstract][Full Text] [Related]
7. Minimization of parathyroid hormone. Novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor. Shimizu M; Potts JT; Gardella TJ J Biol Chem; 2000 Jul; 275(29):21836-43. PubMed ID: 10777513 [TBL] [Abstract][Full Text] [Related]
8. Residues in the membrane-spanning and extracellular loop regions of the parathyroid hormone (PTH)-2 receptor determine signaling selectivity for PTH and PTH-related peptide. Bergwitz C; Jusseaume SA; Luck MD; Jüppner H; Gardella TJ J Biol Chem; 1997 Nov; 272(46):28861-8. PubMed ID: 9360953 [TBL] [Abstract][Full Text] [Related]
9. Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors. Gardella TJ; Luck MD; Jensen GS; Schipani E; Potts JT; Jüppner H Endocrinology; 1996 Sep; 137(9):3936-41. PubMed ID: 8756569 [TBL] [Abstract][Full Text] [Related]
10. Studies of the N-terminal region of a parathyroid hormone-related peptide (1-36) analog: receptor subtype-selective agonists, antagonists, and photochemical cross-linking agents. Carter PH; Jüppner H; Gardella TJ Endocrinology; 1999 Nov; 140(11):4972-81. PubMed ID: 10537121 [TBL] [Abstract][Full Text] [Related]
11. Direct identification of two contact sites for parathyroid hormone (PTH) in the novel PTH-2 receptor using photoaffinity cross-linking. Behar V; Bisello A; Rosenblatt M; Chorev M Endocrinology; 1999 Sep; 140(9):4251-61. PubMed ID: 10465299 [TBL] [Abstract][Full Text] [Related]
13. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. Schipani E; Langman CB; Parfitt AM; Jensen GS; Kikuchi S; Kooh SW; Cole WG; Jüppner H N Engl J Med; 1996 Sep; 335(10):708-14. PubMed ID: 8703170 [TBL] [Abstract][Full Text] [Related]
14. Novel parathyroid hormone (PTH) antagonists that bind to the juxtamembrane portion of the PTH/PTH-related protein receptor. Shimizu N; Dean T; Tsang JC; Khatri A; Potts JT; Gardella TJ J Biol Chem; 2005 Jan; 280(3):1797-807. PubMed ID: 15550385 [TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of the cyclic adenosine 3',5'-monophosphate signaling pathway by parathyroid hormone (PTH)/PTH-related peptide receptors mutated at the two loci for Jansen's metaphyseal chondrodysplasia. Schipani E; Jensen GS; Pincus J; Nissenson RA; Gardella TJ; Jüppner H Mol Endocrinol; 1997 Jun; 11(7):851-8. PubMed ID: 9178745 [TBL] [Abstract][Full Text] [Related]
16. A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia. Schipani E; Langman C; Hunzelman J; Le Merrer M; Loke KY; Dillon MJ; Silve C; Jüppner H J Clin Endocrinol Metab; 1999 Sep; 84(9):3052-7. PubMed ID: 10487664 [TBL] [Abstract][Full Text] [Related]
17. Role of glycosylation in expression and function of the human parathyroid hormone/parathyroid hormone-related protein receptor. Bisello A; Greenberg Z; Behar V; Rosenblatt M; Suva LJ; Chorev M Biochemistry; 1996 Dec; 35(49):15890-5. PubMed ID: 8961954 [TBL] [Abstract][Full Text] [Related]
18. Mapping the bimolecular interface of the parathyroid hormone (PTH)-PTH1 receptor complex: spatial proximity between Lys(27) (of the hormone principal binding domain) and leu(261) (of the first extracellular loop) of the human PTH1 receptor. Greenberg Z; Bisello A; Mierke DF; Rosenblatt M; Chorev M Biochemistry; 2000 Jul; 39(28):8142-52. PubMed ID: 10889020 [TBL] [Abstract][Full Text] [Related]
19. Receptors for PTH and PTHrP: their biological importance and functional properties. Mannstadt M; Jüppner H; Gardella TJ Am J Physiol; 1999 Nov; 277(5):F665-75. PubMed ID: 10564229 [TBL] [Abstract][Full Text] [Related]
20. Tuberoinfundibular peptide (7-39) [TIP(7-39)], a novel, selective, high-affinity antagonist for the parathyroid hormone-1 receptor with no detectable agonist activity. Hoare SR; Usdin TB J Pharmacol Exp Ther; 2000 Nov; 295(2):761-70. PubMed ID: 11046116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]